Departure. Clinical Miss. Billion: Should You Bet on Pfizer?
Pfizer faces a trio of headwinds: a CFO departure, a clinical miss, and a billion-dollar bet on Seagen. This article ...
Credit card perks can vary widely, but knowing what to expect helps you choose wisely. Learn to maximize rewards and enjoy valuable benefits.
13,171 articlesPfizer faces a trio of headwinds: a CFO departure, a clinical miss, and a billion-dollar bet on Seagen. This article ...
Dive into Apple Hospitality (APLE) earnings with a practical lens. This guide explains how occupancy, ADR, and cost c...
As the Fed holds rates, income-focused investors seek reliable yields. This article highlights two dividend stocks ev...
Realtor.com rolls out a refreshed portal strategy focused on MLS partnerships and improved data, signaling a patient,...
Vietnam is turning culture into a growth engine, aiming for 7% of GDP by 2030 and double-digit expansion in cultural ...
When NVIDIA reports earnings on Feb. 25, investors will scan every line for AI demand signals, margin trends, and gui...
Comcast plans a two‑unit split, separating media operations from connectivity services. Investors responded with a 24...
Rechat teams with Canva to streamline listing marketing, letting listing data flow into Canva and back with one click...
Curious about Cerebras stock and its three-year outlook? This guide breaks down growth drivers, risks, and three scen...
Kalshi has closed two insider trading investigations tied to a former California gubernatorial candidate and a mrbeas...
Stocks climbed on Monday after weekend actions in the Middle East, extending a pattern investors have watched in seve...
Brown Harris Stevens adds Debbie Baum, a seasoned Manhattan real estate broker, from Corcoran. The move expands the f...